Solving complex problems to meet patients’ needs is our mission—caring deeply about client programs is our nature
Expertise in both microbial fermentation and chemical synthesis allows us to tackle today’s development pipeline’s increasingly complex molecules. In fact, we thrive on the vexing challenges few CDMOs would have either the expertise or desire to address. Bold vision, along with the passion and commitment to make that vision reality, is at the heart of our organization.
We are a forward-thinking, North American CDMO Pharmaceutical company specializing in clinical-to-commercial scale production capabilities for:
- Synthetic small molecules
- Fermented small molecules
- Highly potent APIs
- Biologics
- Bioreagents
Flexibility, creativity, and dedication to process optimization are at the heart of our method and process development as well as quality and compliance efforts. We assure the programs advance on time and with the highest quality outcomes under our project managers’ leadership.
Our Team Cares About Your Success
Our team comprises a healthy mix of industry veterans with long tenure in the company, a wealth of experience and proven skillsets, as well as newer talent who bring fresh thinking and new perspectives. Together, our team builds on established processes to optimize, adapt, and perfect innovative technologies and drug substance development approaches
“Flexibility is built into our DNA. The ability and dedication to solving our clients’ complex problems, no matter what it takes, is the key to our long-term relationships. ”
— Andrew Mitchell, Senior Director Business Development
BIOVECTRA in numbers
Years of experience
Active clients across five geographic markets
Top pharma and biotech companies supported
Partnered capacity expansion projects since 2003
Employers in Atlantic Canada for four consecutive years
